Fate Therapeutics (FATE) Other Gross PP&E Adjustments (2016 - 2025)
Fate Therapeutics' Other Gross PP&E Adjustments history spans 13 years, with the latest figure at $44.8 million for Q4 2025.
- For Q4 2025, Other Gross PP&E Adjustments fell 0.81% year-over-year to $44.8 million; the TTM value through Dec 2025 reached $44.8 million, down 0.81%, while the annual FY2025 figure was $44.8 million, 0.81% down from the prior year.
- Other Gross PP&E Adjustments reached $44.8 million in Q4 2025 per FATE's latest filing, up from -$42.4 million in the prior quarter.
- In the past five years, Other Gross PP&E Adjustments ranged from a high of $82.8 million in Q4 2023 to a low of -$69.5 million in Q1 2022.
- Average Other Gross PP&E Adjustments over 5 years is -$31.0 million, with a median of -$60.1 million recorded in 2024.
- Peak YoY movement for Other Gross PP&E Adjustments: surged 259.43% in 2021, then tumbled 45.43% in 2024.
- A 5-year view of Other Gross PP&E Adjustments shows it stood at $37.8 million in 2021, then surged by 96.89% to $74.3 million in 2022, then increased by 11.37% to $82.8 million in 2023, then crashed by 45.43% to $45.2 million in 2024, then fell by 0.81% to $44.8 million in 2025.
- Per Business Quant, the three most recent readings for FATE's Other Gross PP&E Adjustments are $44.8 million (Q4 2025), -$42.4 million (Q3 2025), and -$43.8 million (Q2 2025).